Bionime Corp Asset Resilience Ratio
Bionime Corp asset resilience ratio. Bionime Corp (4737) has an Asset Resilience Ratio of 1.10% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Bionime Corp debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Bionime Corp (2009–2025)
Asset resilience ratio of Bionime Corp from 2009 to 2025. This chart shows how Bionime Corp's Asset Resilience Ratio has changed over time. See cash generation quality of Bionime Corp to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Bionime Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Bionime Corp's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$61.97 Million | 1.1% |
| Total Liquid Assets | NT$61.97 Million | 1.10% |
Asset Resilience Insights
- Limited Liquidity: Bionime Corp maintains only 1.10% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Bionime Corp Industry Peers by Asset Resilience Ratio
Compare Bionime Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0 |
Medical Instruments & Supplies | 0.37% |
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101 |
Medical Instruments & Supplies | 47.21% |
|
Medeon Biodesign
TWO:6499 |
Medical Instruments & Supplies | 32.68% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Nextgen
TA:NXGN |
Medical Instruments & Supplies | 3.13% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Bionime Corp Asset Resilience Ratio by Year (2009–2025)
Bionime Corp asset resilience ratio by year from 2009 to 2025. The table below shows the annual Asset Resilience Ratio data for Bionime Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.08% | NT$61.89 Million ≈ $1.95 Million |
NT$5.70 Billion ≈ $179.72 Million |
+0.02pp |
| 2024-12-31 | 1.06% | NT$61.36 Million ≈ $1.93 Million |
NT$5.78 Billion ≈ $182.14 Million |
-0.02pp |
| 2023-12-31 | 1.08% | NT$57.39 Million ≈ $1.81 Million |
NT$5.30 Billion ≈ $167.00 Million |
-0.19pp |
| 2022-12-31 | 1.27% | NT$63.39 Million ≈ $2.00 Million |
NT$4.98 Billion ≈ $156.99 Million |
-0.04pp |
| 2021-12-31 | 1.31% | NT$59.83 Million ≈ $1.88 Million |
NT$4.56 Billion ≈ $143.79 Million |
+0.06pp |
| 2020-12-31 | 1.25% | NT$56.05 Million ≈ $1.77 Million |
NT$4.49 Billion ≈ $141.30 Million |
+0.74pp |
| 2019-12-31 | 0.51% | NT$22.43 Million ≈ $706.64K |
NT$4.40 Billion ≈ $138.76 Million |
-0.33pp |
| 2018-12-31 | 0.84% | NT$38.59 Million ≈ $1.22 Million |
NT$4.59 Billion ≈ $144.59 Million |
-6.30pp |
| 2017-12-31 | 7.14% | NT$312.28 Million ≈ $9.84 Million |
NT$4.37 Billion ≈ $137.83 Million |
-1.47pp |
| 2016-12-31 | 8.61% | NT$400.00 Million ≈ $12.60 Million |
NT$4.65 Billion ≈ $146.39 Million |
+8.17pp |
| 2015-12-31 | 0.44% | NT$19.96 Million ≈ $628.79K |
NT$4.57 Billion ≈ $143.89 Million |
+0.32pp |
| 2012-12-31 | 0.11% | NT$4.10 Million ≈ $129.30K |
NT$3.63 Billion ≈ $114.43 Million |
-0.50pp |
| 2011-12-31 | 0.61% | NT$17.35 Million ≈ $546.56K |
NT$2.85 Billion ≈ $89.82 Million |
-2.12pp |
| 2010-12-31 | 2.73% | NT$35.12 Million ≈ $1.11 Million |
NT$1.29 Billion ≈ $40.55 Million |
-1.06pp |
| 2009-12-31 | 3.79% | NT$33.79 Million ≈ $1.06 Million |
NT$892.09 Million ≈ $28.11 Million |
-- |
About Bionime Corp
Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTE… Read more